Page 4 - Acrx News Today

AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) and China Dongsheng International (OTCMKTS:CDSG – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Insider and Institutional Ownership 15.9% of AcelRx Pharmaceuticals […]

StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) in a research note issued to investors on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Separately, Zacks Investment Research raised AcelRx Pharmaceuticals from a sell rating to a hold rating in a report on Tuesday, February 1st. […]

AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, March 10th. Analysts expect AcelRx Pharmaceuticals to post earnings of ($0.06) per share for the quarter. ACRX stock opened at $0.41 on Friday. The company has a market capitalization of $48.54 million, a PE ratio of […]